Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that...
152 insider purchases on record · latest filing 2026-07-01.
Insiders have also filed 1 sale transaction at NVCT.